Neus Sabaté

ICREA Professor Institut de Microelectrònica de Barcelona
Campus UAB 08193 Bellaterra – Barcelona
This email address is being protected from spambots. You need JavaScript enabled to view it.

From Academic researcher to Co-founding a Spin off! How does the business world work for an academician?

Neus Sabaté studied Physics at the University of Barcelona and started her research career in the field of silicon-based sensors for industrial applications. She obtained her PhD in 2003 at the Microelectronics Institute of Barcelona (IMB-CNM) and joined different research institutions during her postdoc (LAAS–CNRS Toulouse, University of Barcelona, IZM Fraunhofer Berlin). Back to IMB-CNM in 2006 she started a research line in microfabricated fuel cells that evolved to the biodegradable electrochemical power sources she develops today. In 2015 she obtained an ERC-Consolidator Grant to develop single-use paper fuel cells as key components of a new generation of affordable and efficient point-of-care devices. She also co-founded Fuelium SL in 2016, a spin-off company that aims to commercialize paper batteries and autonomous and simple solutions for single use devices in the diagnostic sector. The spin-off is running successfully for the fourth year now and she will be here to share with us the journey from academy to entrepreneurship, its perks, failures, challenges and of course the road to success!

Zoe Boyer

Project Coordinator & Associate Scientist at Barcelona Liver Bioservices (BLB)

Development of a human liver on a chip: when vascular biologists, hepatologists and bioengineers meet

Zoe Boyer is project coordinator & associate scientist at Barcelona Liver Bioservices (BLB), a contract research organization that aims to contribute with pharmaceutical partners to ultimately accelerate the development of new treatments for patients with liver disease. BLB has developed the patent-protected ExoLiver platform (Liver-on-a-chip). ExoLiver mimics the human liver microenvironment through the combination of co-culture of primary human liver cells, constant stimulation of the endothelial cell layer with microfluidic shear stress, and continuous paracrine interactions between all cell types and, therefore, constitutes a useful tool to understand the mechanisms of action of new chemical entities or to investigate the possible hepatotoxicity of novel compounds.

Salvador Ferrer Fábregas

Scientific Assistant at ALBA Synchrotron, Barcelona Synchrotron Park, Cerdanyola del Valles, Barcelona

Introduction to Synchrotron Radiation and recent results from ALBA

Prof. Salvador Ferrer Fábregas is a physics graduate (University of Barcelona) and Doctor of Physics (Autonomous University of Madrid). His scientific career is focussed on surface chemistry and surface physics, especially the magnetic properties of the surface of materials. He has taught at the Autonomous University of Madrid and did postdoctoral research at Berkeley (California, USA). Since 1988 Salvador has been working with synchrotron beamlines. He was the principal beamline scientist at the European Synchrotron in Grenoble (France) from 1988 to 2004 and he has since then worked at the Alba synchrotron, where he was Research Director until 2011. Presently, he is an Associate Scientific Advisor at ALBA since 2012. He has participated in “How the ALBA Synchrotron aids in quantum information. Research into materials and surfaces.” Also he has been honored with the Spanish Vacuum Society (ASEVA) “All a devoted career” award for his outstanding contributions to the study of surface properties and to the development of characterization experimental techniques, noticeably in the field of X-ray diffraction, and for his crucial contribution to the creation and operation of the ALBA Synchrotron. At the JPhD2020 guest lecture, he will share with us about the incredible synchrotron technology and its potential applications, as well as some of the recent results from ALBA synchrotron centre.

Irene Rius Ruiz

Translational cancer researcher, Vall d'Hebron Institute of Oncology (VHIO), Centro Cellex, Barcelona          This email address is being protected from spambots. You need JavaScript enabled to view it.

From bench to bedside: Understanding the preclinical development of CAR Ts and how to bring them into the clinics.
Irene Rius studied at University of Aarhus, Denmark, “Novel effects of insertional mutagenesis by murine leukemia virus” just before moving to her master studies at Imperial College London where she worked on both, the Department of Cancer and Surgery and the National Heart and Lung Institute, in field of cancer immunology. Recently, she obtained her PhD, in 2019, at the Vall d’Hebron Institute of Oncology, Spain, under the project “Immunotherapies against HER2-positive breast cancers”.
Now she continues her work within the field of cancer immunotherapies, working on the generation and characterization of CAR T cells against a subtype of HER2 positive breast cancer, in Vall d’Hebron Institute of Oncology, as a postdoctoral researcher. 
“Cancer Immunotherapy” named as “breakthrough of the year 2013” has been one of the most tremendous discoveries in cancer therapies of this decade and has gained a constantly increasing attention, rightfully so. Indeed, it is a pleasure to have with us, such a young highly motivated biochemist providing us some insights about the topic: “From bench to bedside: understanding the preclinical development of CAR Ts and how to bring them into the clinics”.